Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026)
Acumen Pharmaceuticals (ABOS) reported Other Non-Current Assets of $263,000 for Q2 2026, down 43.3% from $464,000 a year earlier and down 13.5% from the prior quarter.
Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Acumen Pharmaceuticals posted Other Non-Current Assets of $350,000, down 28.0% from FY2024.
- Other Non-Current Assets has a four-year compound annual growth rate of 123.6% (FY2021 to FY2025).
- By year, Other Non-Current Assets came in at $486,000 in FY2024 (-32.9%), $724,000 in FY2023 (+379.5%), $151,000 in FY2022 (+978.6%) and $14,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets since Q3 2024.
- Year over year, Other Non-Current Assets has now declined in each of the last three quarters, with growth averaging 1.5% over the last eight quarters.
- The high point for year-over-year Other Non-Current Assets in five years was Q4 2022 (growth of 978.6%); the low point was Q2 2022 (a decline of 89.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $304,000 (Q1 2026), $350,000 (Q4 2025) and $393,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Acumen Pharmaceuticals | 147.03 Mn | -335.04 Mn | - | 725,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 725,000.00 |
| Mar 31, 2026 | 766,000.00 |
| Dec 31, 2025 | 812,000.00 |
| Sep 30, 2025 | 857,000.00 |
| Jun 30, 2025 | 464,000.00 |
| Mar 31, 2025 | 968,000.00 |
| Dec 31, 2024 | 950,000.00 |
| Sep 30, 2024 | 642,000.00 |
| Jun 30, 2024 | 895,000.00 |
| Mar 31, 2024 | 792,000.00 |
| Dec 31, 2023 | 957,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 391,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Jun 30, 2022 | 344,000.00 |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 2.37 Mn |
Acumen Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();